We found that STAT1 and c-Myc mRNA and protein expressions were decreased in the miR-146a inhibitor-treated cells compared with NC inhibitor treated cells in both cellular AD models, which implied that the miR-146a inhibition suppressed the STAT1/MYC pathway in AD. Here, STAT1 is linked to Alzheimer disease.